Alcohol use disorder and initiation of oral anticoagulant therapy in patients with atrial fibrillation: a nationwide cohort study

Back

EHRA Premium Access

Alcohol use disorder and initiation of oral anticoagulant therapy in patients with atrial fibrillation: a nationwide cohort study

Session: Stroke prevention

Topic: Oral Anticoagulation

Speaker: Mr M. Vanhanen (Turku, FI)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Mr Miika Hermanni Vanhanen

Turku (Finland)

0 follower

6 more presentations in this session

Boosting anticoagulation adherence in atrial fibrillation and atrial flutter: the impact of a simple nudge strategy before elective electrical cardioversion

Speaker: Doctor P. Mangas Palma (Porto, PT)

In-hospital outcomes of left atrial appendage (LAA) occlusion among cancer patients with atrial fibrillation: a nationwide US study

Speaker: Associate Professor E. Leshem (Hadera, IL)

Extraction of Watchman device using a double transeptal approach

Speaker: Doctor V. La Fazia (Austin, US)

What is the stroke risk threshold for anticoagulation to provide net benefit in atrial fibrillation? A Markov decision model analysis

Speaker: Doctor K. Teppo (Turku, FI)

Peri-device sealing and procedural outcomes of LAA closure: a comparative study of device types in patients with and without LAA isolation

Speaker: Doctor H. Alessandrini (Luebeck, DE)

Access the full session

Stroke prevention

Speakers: Mr M. Vanhanen, Doctor P. Mangas Palma, Associate Professor E. Leshem, Doctor V. La Fazia, Doctor K. Teppo...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources